Specify a stock or a cryptocurrency in the search bar to get a summary
Anebulo Pharmaceuticals Inc
ANEBAnebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas. Address: 1017 Ranch Road 620 South, Lakeway, TX, United States, 78734
Analytics
WallStreet Target Price
6 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ANEB
Dividend Analytics ANEB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ANEB
Stock Valuation ANEB
Financials ANEB
Results | 2019 | Dynamics |